ID   LIPC_HUMAN              Reviewed;         499 AA.
AC   P11150; A2RUB4; A8K9B6; O43571; P78529; Q99465;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   10-MAY-2017, entry version 187.
DE   RecName: Full=Hepatic triacylglycerol lipase;
DE            Short=HL;
DE            Short=Hepatic lipase;
DE            EC=3.1.1.3;
DE   AltName: Full=Lipase member C;
DE   Flags: Precursor;
GN   Name=LIPC; Synonyms=HTGL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS SER-215 AND LEU-356.
RC   TISSUE=Liver;
RX   PubMed=2828141; DOI=10.1111/j.1432-0436.1987.tb00150.x;
RA   Stahnke G., Sprengel R., Augustin J., Will H.;
RT   "Human hepatic triglyceride lipase: cDNA cloning, amino acid sequence
RT   and expression in a cultured cell line.";
RL   Differentiation 35:45-52(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS SER-215 AND LEU-356.
RC   TISSUE=Liver;
RX   PubMed=2447084;
RA   Datta S., Luo C.C., Li W.H., VanTuinen P., Ledbetter D.H., Brown M.A.,
RA   Chen S.H., Liu S., Chan L.;
RT   "Human hepatic lipase. Cloned cDNA sequence, restriction fragment
RT   length polymorphisms, chromosomal localization, and evolutionary
RT   relationships with lipoprotein lipase and pancreatic lipase.";
RL   J. Biol. Chem. 263:1107-1110(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND VARIANT
RP   LEU-356.
RC   TISSUE=Liver;
RX   PubMed=2839510;
RA   Martin G.A., Busch S.J., Meredith G.D., Cardin A.D., Blankenship D.T.,
RA   Mao S.J.T., Rechtin A.E., Woods C.W., Racke M.M., Schafer M.P.,
RA   Fitzgerald M.C., Burke D.M., Flanagan M.A., Jackson R.L.;
RT   "Isolation and cDNA sequence of human postheparin plasma hepatic
RT   triglyceride lipase.";
RL   J. Biol. Chem. 263:10907-10914(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LEU-356.
RX   PubMed=2605236; DOI=10.1021/bi00449a002;
RA   Cai S.J., Wong D.M., Chen S.H., Chan L.;
RT   "Structure of the human hepatic triglyceride lipase gene.";
RL   Biochemistry 28:8966-8971(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-215 AND LEU-356.
RX   PubMed=2324091;
RA   Ameis D., Stahnke G., Kobayashi J., McLean J., Lee G., Buscher M.,
RA   Schotz M.C., Will H.;
RT   "Isolation and characterization of the human hepatic lipase gene.";
RL   J. Biol. Chem. 265:6552-6555(1990).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS SER-215 AND
RP   LEU-356.
RC   TISSUE=Kidney, and Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-356.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 92-152, AND VARIANT HL DEFICIENCY
RP   HIS-TYR-THR-VAL-ALA-VAL-134 INS.
RX   PubMed=10660332;
RA   Tiebel O., Gehrisch S., Pietzsch J., Gromeier S., Jaross W.;
RT   "18 bp insertion/duplication with internal missense mutation in human
RT   hepatic lipase gene exon 3.";
RL   Hum. Mutat. 12:216-216(1998).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 464-499.
RX   PubMed=8865180; DOI=10.1006/mcpr.1996.0041;
RA   Takagi A., Ikeda Y., Mori A., Ashida Y., Yamamoto A.;
RT   "Identification of a BstNI polymorphism in exon 9 of the human hepatic
RT   triglyceride lipase gene.";
RL   Mol. Cell. Probes 10:313-314(1996).
RN   [11]
RP   ASSOCIATION WITH NIDDM SUSCEPTIBILITY.
RX   PubMed=15126514; DOI=10.1210/jc.2003-031325;
RA   Todorova B., Kubaszek A., Pihlajamaki J., Lindstrom J., Eriksson J.,
RA   Valle T.T., Hamalainen H., Ilanne-Parikka P.,
RA   Keinanen-Kiukaanniemi S., Tuomilehto J., Uusitupa M., Laakso M.;
RT   "The G-250A promoter polymorphism of the hepatic lipase gene predicts
RT   the conversion from impaired glucose tolerance to type 2 diabetes
RT   mellitus: the Finnish diabetes prevention study.";
RL   J. Clin. Endocrinol. Metab. 89:2019-2023(2004).
RN   [12]
RP   INVOLVEMENT IN HDLCQ12.
RX   PubMed=18364377; DOI=10.1210/jc.2007-2815;
RA   Grarup N., Andreasen C.H., Andersen M.K., Albrechtsen A., Sandbaek A.,
RA   Lauritzen T., Borch-Johnsen K., Jorgensen T., Schmitz O., Hansen T.,
RA   Pedersen O.;
RT   "The -250G>A promoter variant in hepatic lipase associates with
RT   elevated fasting serum high-density lipoprotein cholesterol modulated
RT   by interaction with physical activity in a study of 16,156 Danish
RT   subjects.";
RL   J. Clin. Endocrinol. Metab. 93:2294-2299(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   VARIANTS HL DEFICIENCY PHE-289 AND MET-405.
RX   PubMed=1301939; DOI=10.1002/humu.1380010410;
RA   Hegele R.A., Tu L., Connelly P.W.;
RT   "Human hepatic lipase mutations and polymorphisms.";
RL   Hum. Mutat. 1:320-324(1992).
RN   [15]
RP   REVIEW ON POLYMORPHISM.
RA   Hayden M.R., Ma Y., Brunzell J., Henderson H.E.;
RT   "Genetic variants affecting human lipoprotein and hepatic lipases.";
RL   Curr. Opin. Lipidol. 2:104-109(1991).
RN   [16]
RP   VARIANTS MET-95; SER-215 AND ASN-440.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [17]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
RN   [18]
RP   VARIANTS MET-95; SER-215; PHE-289; ILE-342; LEU-356; MET-405 AND
RP   ALA-409.
RX   PubMed=12966036; DOI=10.1093/hmg/ddg314;
RA   Morabia A., Cayanis E., Costanza M.C., Ross B.M., Flaherty M.S.,
RA   Alvin G.B., Das K., Gilliam T.C.;
RT   "Association of extreme blood lipid profile phenotypic variation with
RT   11 reverse cholesterol transport genes and 10 non-genetic
RT   cardiovascular disease risk factors.";
RL   Hum. Mol. Genet. 12:2733-2743(2003).
CC   -!- FUNCTION: Hepatic lipase has the capacity to catalyze hydrolysis
CC       of phospholipids, mono-, di-, and triglycerides, and acyl-CoA
CC       thioesters. It is an important enzyme in HDL metabolism. Hepatic
CC       lipase binds heparin.
CC   -!- CATALYTIC ACTIVITY: Triacylglycerol + H(2)O = diacylglycerol + a
CC       carboxylate.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- POLYMORPHISM: Genetic variations in LIPC define the high density
CC       lipoprotein cholesterol level quantitative trait locus 12
CC       (HDLCQ12) [MIM:612797]. {ECO:0000269|PubMed:18364377}.
CC   -!- POLYMORPHISM: Genetic variations in LIPC are associated with non-
CC       insulin-dependent diabetes mellitus susceptibility (NIDDM
CC       susceptibility) [MIM:125853]. {ECO:0000269|PubMed:15126514}.
CC   -!- DISEASE: Hepatic lipase deficiency (HL deficiency) [MIM:614025]: A
CC       disorder characterized by elevated levels of beta-migrating very
CC       low density lipoproteins, and abnormally triglyceride-rich low and
CC       high density lipoproteins. {ECO:0000269|PubMed:10660332,
CC       ECO:0000269|PubMed:1301939}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the AB hydrolase superfamily. Lipase
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=LIPC";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D83548; BAA12014.1; -; mRNA.
DR   EMBL; X07228; CAA30188.1; -; mRNA.
DR   EMBL; J03540; AAA59520.1; -; mRNA.
DR   EMBL; J03895; AAA61165.1; -; mRNA.
DR   EMBL; M29194; AAB60702.1; -; Genomic_DNA.
DR   EMBL; M29186; AAB60702.1; JOINED; Genomic_DNA.
DR   EMBL; M29187; AAB60702.1; JOINED; Genomic_DNA.
DR   EMBL; M29188; AAB60702.1; JOINED; Genomic_DNA.
DR   EMBL; M29189; AAB60702.1; JOINED; Genomic_DNA.
DR   EMBL; M29190; AAB60702.1; JOINED; Genomic_DNA.
DR   EMBL; M29191; AAB60702.1; JOINED; Genomic_DNA.
DR   EMBL; M29192; AAB60702.1; JOINED; Genomic_DNA.
DR   EMBL; M29193; AAB60702.1; JOINED; Genomic_DNA.
DR   EMBL; D83062; BAA11760.1; -; Genomic_DNA.
DR   EMBL; M35433; AAA59521.1; -; Genomic_DNA.
DR   EMBL; M35425; AAA59521.1; JOINED; Genomic_DNA.
DR   EMBL; M35426; AAA59521.1; JOINED; Genomic_DNA.
DR   EMBL; M35427; AAA59521.1; JOINED; Genomic_DNA.
DR   EMBL; M35429; AAA59521.1; JOINED; Genomic_DNA.
DR   EMBL; M35430; AAA59521.1; JOINED; Genomic_DNA.
DR   EMBL; M35431; AAA59521.1; JOINED; Genomic_DNA.
DR   EMBL; M35432; AAA59521.1; JOINED; Genomic_DNA.
DR   EMBL; AK292631; BAF85320.1; -; mRNA.
DR   EMBL; AK315306; BAG37710.1; -; mRNA.
DR   EMBL; AC018904; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC084781; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC132825; AAI32826.1; -; mRNA.
DR   EMBL; BC136495; AAI36496.1; -; mRNA.
DR   EMBL; AF037404; AAC34206.1; -; Genomic_DNA.
DR   CCDS; CCDS10166.1; -.
DR   PIR; A28997; A28997.
DR   RefSeq; NP_000227.2; NM_000236.2.
DR   RefSeq; XP_005254429.1; XM_005254372.1.
DR   UniGene; Hs.654472; -.
DR   ProteinModelPortal; P11150; -.
DR   BioGrid; 110178; 6.
DR   IntAct; P11150; 1.
DR   STRING; 9606.ENSP00000299022; -.
DR   BindingDB; P11150; -.
DR   ChEMBL; CHEMBL2127; -.
DR   SwissLipids; SLP:000000569; -.
DR   ESTHER; human-LIPC; Hepatic_Lipase.
DR   iPTMnet; P11150; -.
DR   PhosphoSitePlus; P11150; -.
DR   BioMuta; LIPC; -.
DR   DMDM; 317373430; -.
DR   PaxDb; P11150; -.
DR   PeptideAtlas; P11150; -.
DR   PRIDE; P11150; -.
DR   DNASU; 3990; -.
DR   Ensembl; ENST00000299022; ENSP00000299022; ENSG00000166035.
DR   Ensembl; ENST00000356113; ENSP00000348425; ENSG00000166035.
DR   GeneID; 3990; -.
DR   KEGG; hsa:3990; -.
DR   UCSC; uc002afa.3; human.
DR   CTD; 3990; -.
DR   DisGeNET; 3990; -.
DR   GeneCards; LIPC; -.
DR   H-InvDB; HIX0038150; -.
DR   HGNC; HGNC:6619; LIPC.
DR   MalaCards; LIPC; -.
DR   MIM; 125853; phenotype.
DR   MIM; 151670; gene.
DR   MIM; 612797; phenotype.
DR   MIM; 614025; phenotype.
DR   neXtProt; NX_P11150; -.
DR   OpenTargets; ENSG00000166035; -.
DR   Orphanet; 140905; Hyperlipidemia due to hepatic triglyceride lipase deficiency.
DR   PharmGKB; PA230; -.
DR   eggNOG; ENOG410IIHP; Eukaryota.
DR   eggNOG; ENOG4110MCZ; LUCA.
DR   GeneTree; ENSGT00760000119069; -.
DR   HOGENOM; HOG000038553; -.
DR   HOVERGEN; HBG002259; -.
DR   InParanoid; P11150; -.
DR   KO; K01046; -.
DR   OrthoDB; EOG091G052B; -.
DR   PhylomeDB; P11150; -.
DR   TreeFam; TF324997; -.
DR   Reactome; R-HSA-174800; Chylomicron-mediated lipid transport.
DR   Reactome; R-HSA-192456; Digestion of dietary lipid.
DR   ChiTaRS; LIPC; human.
DR   GeneWiki; Hepatic_lipase; -.
DR   GenomeRNAi; 3990; -.
DR   PRO; PR:P11150; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000166035; -.
DR   CleanEx; HS_LIPC; -.
DR   ExpressionAtlas; P11150; baseline and differential.
DR   Genevisible; P11150; HS.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0034364; C:high-density lipoprotein particle; IEA:UniProtKB-KW.
DR   GO; GO:0034185; F:apolipoprotein binding; ISS:BHF-UCL.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0030169; F:low-density lipoprotein particle binding; ISS:BHF-UCL.
DR   GO; GO:0004620; F:phospholipase activity; TAS:BHF-UCL.
DR   GO; GO:0004806; F:triglyceride lipase activity; IDA:BHF-UCL.
DR   GO; GO:0042632; P:cholesterol homeostasis; IMP:BHF-UCL.
DR   GO; GO:0008203; P:cholesterol metabolic process; IEA:Ensembl.
DR   GO; GO:0034382; P:chylomicron remnant clearance; TAS:BHF-UCL.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0034375; P:high-density lipoprotein particle remodeling; IMP:BHF-UCL.
DR   GO; GO:0034373; P:intermediate-density lipoprotein particle remodeling; TAS:BHF-UCL.
DR   GO; GO:0044241; P:lipid digestion; TAS:Reactome.
DR   GO; GO:0034374; P:low-density lipoprotein particle remodeling; IMP:BHF-UCL.
DR   GO; GO:0034638; P:phosphatidylcholine catabolic process; TAS:BHF-UCL.
DR   GO; GO:0043691; P:reverse cholesterol transport; IC:BHF-UCL.
DR   GO; GO:0019433; P:triglyceride catabolic process; IDA:BHF-UCL.
DR   GO; GO:0070328; P:triglyceride homeostasis; IMP:BHF-UCL.
DR   GO; GO:0034372; P:very-low-density lipoprotein particle remodeling; IDA:BHF-UCL.
DR   CDD; cd00707; Pancreat_lipase_like; 1.
DR   Gene3D; 2.60.60.20; -; 1.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR013818; Lipase/vitellogenin.
DR   InterPro; IPR002333; Lipase_hep.
DR   InterPro; IPR016272; Lipase_LIPH.
DR   InterPro; IPR033906; Lipase_N.
DR   InterPro; IPR001024; PLAT/LH2_dom.
DR   InterPro; IPR000734; TAG_lipase.
DR   PANTHER; PTHR11610; PTHR11610; 1.
DR   PANTHER; PTHR11610:SF139; PTHR11610:SF139; 1.
DR   Pfam; PF00151; Lipase; 1.
DR   Pfam; PF01477; PLAT; 1.
DR   PIRSF; PIRSF000865; Lipoprotein_lipase_LIPH; 1.
DR   PRINTS; PR00824; HEPLIPASE.
DR   PRINTS; PR00821; TAGLIPASE.
DR   SMART; SM00308; LH2; 1.
DR   SUPFAM; SSF49723; SSF49723; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
DR   PROSITE; PS00120; LIPASE_SER; 1.
DR   PROSITE; PS50095; PLAT; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Direct protein sequencing; Disease mutation;
KW   Glycoprotein; HDL; Heparin-binding; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Polymorphism; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     22
FT   CHAIN        23    499       Hepatic triacylglycerol lipase.
FT                                /FTId=PRO_0000017769.
FT   DOMAIN      352    486       PLAT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00152}.
FT   REGION      181    193       Heparin-binding. {ECO:0000255}.
FT   ACT_SITE    168    168       Nucleophile. {ECO:0000250}.
FT   ACT_SITE    194    194       Charge relay system.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10037}.
FT   ACT_SITE    279    279       Charge relay system.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10037}.
FT   CARBOHYD     42     42       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     78     78       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    362    362       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    397    397       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      95     95       V -> M (in dbSNP:rs6078).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:12966036}.
FT                                /FTId=VAR_004206.
FT   VARIANT     134    134       V -> VHYTVAV (in HL deficiency).
FT                                {ECO:0000269|PubMed:10660332}.
FT                                /FTId=VAR_004207.
FT   VARIANT     215    215       N -> S (in dbSNP:rs6083).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:12966036,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:2324091,
FT                                ECO:0000269|PubMed:2447084,
FT                                ECO:0000269|PubMed:2828141}.
FT                                /FTId=VAR_004208.
FT   VARIANT     289    289       S -> F (in HL deficiency;
FT                                dbSNP:rs121912502).
FT                                {ECO:0000269|PubMed:12966036,
FT                                ECO:0000269|PubMed:1301939}.
FT                                /FTId=VAR_004209.
FT   VARIANT     342    342       V -> I (in dbSNP:rs145811475).
FT                                {ECO:0000269|PubMed:12966036}.
FT                                /FTId=VAR_017024.
FT   VARIANT     356    356       F -> L (in dbSNP:rs3829462).
FT                                {ECO:0000269|PubMed:12966036,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:2324091,
FT                                ECO:0000269|PubMed:2447084,
FT                                ECO:0000269|PubMed:2605236,
FT                                ECO:0000269|PubMed:2828141,
FT                                ECO:0000269|PubMed:2839510}.
FT                                /FTId=VAR_017025.
FT   VARIANT     405    405       T -> M (in HL deficiency;
FT                                dbSNP:rs113298164).
FT                                {ECO:0000269|PubMed:12966036,
FT                                ECO:0000269|PubMed:1301939}.
FT                                /FTId=VAR_004210.
FT   VARIANT     409    409       D -> A (in dbSNP:rs142036980).
FT                                {ECO:0000269|PubMed:12966036}.
FT                                /FTId=VAR_017026.
FT   VARIANT     440    440       S -> N (in dbSNP:rs6079).
FT                                {ECO:0000269|PubMed:10391209}.
FT                                /FTId=VAR_014179.
FT   CONFLICT    256    256       F -> S (in Ref. 1; AAA61165).
FT                                {ECO:0000305}.
SQ   SEQUENCE   499 AA;  55914 MW;  1FC7567CAE3E514B CRC64;
     MDTSPLCFSI LLVLCIFIQS SALGQSLKPE PFGRRAQAVE TNKTLHEMKT RFLLFGETNQ
     GCQIRINHPD TLQECGFNSS LPLVMIIHGW SVDGVLENWI WQMVAALKSQ PAQPVNVGLV
     DWITLAHDHY TIAVRNTRLV GKEVAALLRW LEESVQLSRS HVHLIGYSLG AHVSGFAGSS
     IGGTHKIGRI TGLDAAGPLF EGSAPSNRLS PDDANFVDAI HTFTREHMGL SVGIKQPIGH
     YDFYPNGGSF QPGCHFLELY RHIAQHGFNA ITQTIKCSHE RSVHLFIDSL LHAGTQSMAY
     PCGDMNSFSQ GLCLSCKKGR CNTLGYHVRQ EPRSKSKRLF LVTRAQSPFK VYHYQFKIQF
     INQTETPIQT TFTMSLLGTK EKMQKIPITL GKGIASNKTY SFLITLDVDI GELIMIKFKW
     ENSAVWANVW DTVQTIIPWS TGPRHSGLVL KTIRVKAGET QQRMTFCSEN TDDLLLRPTQ
     EKIFVKCEIK SKTSKRKIR
//
